171 related articles for article (PubMed ID: 3149571)
1. UFT is more antineoplastic against gastric carcinoma than 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil and 1-hexylcarbamoyl-5-fluorouracil.
Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sugimachi K
Chemotherapy; 1988; 34(6):484-9. PubMed ID: 3149571
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity test for 5-fluorouracil and its analogues, 1-(2-tetrahydrofuryl)-5-fluorouracil, uracil/1-(2-tetrahydrofuryl)-5-fluorouracil (4:1) and 1-hexylcarbamoyl-5-fluorouracil, using the subrenal capsule assay.
Anai H; Maehara Y; Kusumoto H; Kusumoto T; Sugimachi K
Oncology; 1988; 45(3):144-7. PubMed ID: 3130595
[TBL] [Abstract][Full Text] [Related]
3. [Chemosensitivity testing for 5-FU and 5-FU derivatives using subrenal capsule assay].
Anai H; Maehara Y; Kusumoto H; Masuda H; Sugimachi K
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):635-8. PubMed ID: 3103537
[TBL] [Abstract][Full Text] [Related]
4. [Human colorectal carcinoma is more sensitive to HCFU than 5-FU and tegafur in in vitro and in vivo drug sensitivity tests].
Kusumoto T; Maehara Y; Anai H; Kusumoto H; Miyamoto K; Fukuchi K; Sugimachi K
Gan To Kagaku Ryoho; 1988 Feb; 15(2):257-61. PubMed ID: 3124767
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil and UFT-sensitive gastric carcinoma has a high level of thymidylate synthase.
Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sakaguchi Y; Kido Y; Okamura T; Korenaga D; Sugimachi K
Cancer; 1989 May; 63(9):1693-6. PubMed ID: 2495166
[TBL] [Abstract][Full Text] [Related]
6. [Chemosensitivity of head and neck squamous cell carcinomas using subrenal capsule assay--comparative assay of 5-FU, FT, UFT, and HCFU and immunohistochemical study].
Nakashima T; Miyagi M; Kusumoto T
Nihon Jibiinkoka Gakkai Kaiho; 1992 Jan; 95(1):95-103. PubMed ID: 1545316
[TBL] [Abstract][Full Text] [Related]
7. The antiproliferative effects of fluoropyrimidine derivatives against human tumor xenografts in a subrenal capsule assay.
Nishiyama M; Takagami S; Kirihara Y; Saeki T; Hirabayashi N; Nosoh Y; Niimoto M; Hattori T
Jpn J Surg; 1988 Nov; 18(6):725-8. PubMed ID: 2977626
[TBL] [Abstract][Full Text] [Related]
8. [Combined effects of interferon alpha-A/D with fluoropyrimidine derivatives in the subrenal capsule assay].
Nishiyama M; Takagami S; Kirihara Y; Saeki T; Niimi K; Kim R; Jinushi K; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2285-90. PubMed ID: 3136700
[TBL] [Abstract][Full Text] [Related]
9. Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine.
Ooi A; Ohkubo T; Higashigawa M; Kawasaki H; Kakito H; Kagawa Y; Kojima M; Sakurai M
Biol Pharm Bull; 2001 Nov; 24(11):1329-31. PubMed ID: 11725974
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur.
Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041
[TBL] [Abstract][Full Text] [Related]
11. General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil.
Yamamoto J; Toide K; Haruno A; Yoshimura Y; Unemi N
Arzneimittelforschung; 1981; 31(8):1268-78. PubMed ID: 6794578
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
13. Clinical basis of chemotherapy for gastric cancer with uracil and 1-(2'-tetrahydrofuryl)-5-fluorouracil.
Kimura K; Suga S; Shimaji T; Kitamura M; Kubo K; Suzuoki Y; Isobe K
Gastroenterol Jpn; 1980; 15(4):324-9. PubMed ID: 6773844
[TBL] [Abstract][Full Text] [Related]
14. Dipyridamole augments the antitumor effects of fluorinated pyrimidines.
Sakaguchi Y; Kusumoto T; Kusumoto H; Maehara Y; Furusawa M; Sugimachi K
Anticancer Res; 1992; 12(1):119-21. PubMed ID: 1567156
[TBL] [Abstract][Full Text] [Related]
15. [In vivo chemosensitivity test for UFT and FT-207. I--Subrenal capsule assay].
Nishiyama M; Niimi K; Yamaguchi M; Hirabayashi N; Nosoh Y; Tohge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):109-13. PubMed ID: 3099648
[TBL] [Abstract][Full Text] [Related]
16. Studies on the metabolism of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil co-administered orally to tumor-bearing rats.
Kawaguchi Y; Nagayama S; Masuda H; Yasuda A
Gan; 1980 Dec; 71(6):889-99. PubMed ID: 6791982
[TBL] [Abstract][Full Text] [Related]
17. [5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207].
Takeshita M; Ishikawa H; Seki M; Ikeya T; Miyamoto Y; Izuo M; Tozuka S; Usui R; Kaneko H
Gan No Rinsho; 1985 Oct; 31(13):1697-703. PubMed ID: 3935831
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermia enhances the inhibition of tumor growth by 1-(2-tetrahydrofuryl)-5-fluorouracil/uracil (1:4) in tumors in mice and humans.
Emi Y; Kohnoe S; Yoshida M; Takahashi I; Maehara Y; Sugimachi K
Cancer; 1992 Sep; 70(5):1177-82. PubMed ID: 1515994
[TBL] [Abstract][Full Text] [Related]
19. 5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil.
Tsujimoto S; Fujimoto K; Okajima E; Ozono S; Okajima E; Hirao Y
Int J Clin Oncol; 2008 Apr; 13(2):138-43. PubMed ID: 18463958
[TBL] [Abstract][Full Text] [Related]
20. Anticancer drug distribution in lymph and blood during adjuvant chemotherapy after surgery for gastric carcinoma. A study with a combined preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil.
Hanaue H; Kurosawa T; Kitano Y; Miyakawa S; Nemoto A; Yamamoto H; Asagoe T; Takada T; Yasuda H; Shikata J
Cancer; 1987 May; 59(9):1571-6. PubMed ID: 3103905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]